Harmony Biosciences Reiterates 2026 Wakix Revenue Guidance
Harmony Biosciences reiterated its 2026 Wakix net revenue guidance of $1.0 billion to $1.04 billion.
Harmony Biosciences reiterated its 2026 Wakix net revenue guidance of $1.0 billion to $1.04 billion.